MedPath

A randomized controlled trial to evaluate the effectiveness of clinical pharmacy service on improving the quality of life and use of medicines in oncology patients at the National Cancer Institute in Sri Lanka.

Not Applicable
Not yet recruiting
Conditions
Cancer
Registration Number
SLCTR/2020/002
Lead Sponsor
Faculty of Medicine, University of Kelaniya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

1. Patients age 18 years old or above
2. Male and female patients
3. Patients diagnosed with cancer at any stage by an oncologist
4. Patients undergoing their 1st and 2nd cycles of chemotherapy

Exclusion Criteria

1. Patients re-admitted during the study period
2. Patients with poor cognition with no caregiver to manage medicines
3. Patients who unable/unwilling to give informed written consent
4. Patients who already undergone 3rd cycle of chemotherapy onwards
5. Patients who have speech and communication disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.